Dispatch Bio Sales Trigger

🚀 Battle Card: Dispatch Bio

• Mauro Avanzi, M.D., Ph.D., Chief Medical Officer · 🔗 [LinkedIn](https://www.linkedin.com/company/dispatch-bio/about/)

• Seasoned CMO with deep immuno-oncology and clinical development prowess will accelerate first-in-human Flare platform trials → Source

• Lack of in-house clinical execution framework for early-phase oncology trials

• Regulatory complexity for novel Flare platform IND applications

• Primary: Clinical Trial Management System (CTMS) → Streamlined trial setup & monitoring

• Expansion: Regulatory Affairs Consulting → Faster IND submissions and approvals

• HQ: Philadelphia, PA & San Francisco, CA

• Employees: ≈ 120

• Rev: ≈ $10 M

• Website: [dispatchbio.com](https://www.dispatchbio.com)

🤼 Competitive Intel

• Veeva — CTMS / eTMF
• Unique edge: Industry-leading life sciences CRM integration
• Evaluated by CMO for global trial footprint

• Medidata — CTMS / eClinical
• Unique edge: End-to-end trial analytics
• Evaluated by Head of Clinical Ops for data insights

• Oracle Health Sciences — CTMS / eData
• Unique edge: Scalable enterprise solutions
• Evaluated by VP of Regulatory for compliance depth

• PRA Health Sciences — CRO services
• Unique edge: Full-service clinical research
• Evaluated by Clinical Ops for outsourced trial execution

• Syneos Health — CRO / Consulting
• Unique edge: Integrated commercialization support
• Evaluated by CEO for go-to-market alignment

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑≈ TBD❑
OFFER_BRIEF   = ❑A Clinical Trial Management System to streamline early-phase oncology trial setup and monitoring.❑
PROOF_METRIC  = ❑≈ TBD❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Mauro
COMPANY     = Dispatch Bio
DEPT        = Clinical Development
SIZE        = ≈ TBD
BOTTLENECK  = lack of in-house clinical execution framework for early-phase oncology trials
EVENT       = CMO appointment
DETAIL      = your appointment as Chief Medical Officer
PAIN        = lack of in-house clinical execution framework for early-phase oncology trials
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250929659486&div=41152219
SIM_CO      = ≈ TBD
WIN_METRIC  = ≈ TBD
NEXT_SIZE   = ≈ TBD
EMP_EST     = ≈ 120
REV_EST     = ≈ $10 M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈ TBD-person Clinical Development

Mauro—noticed your Clinical Development team is ≈ TBD.

That’s when lack of in-house clinical execution framework for early-phase oncology trials slows growth.

We helped ≈ TBD fix this with A Clinical Trial Management System to streamline early-phase oncology trial setup and monitoring.

Result: ≈ TBD.  
Quick call?

PS—next bottleneck hits ≈ TBD.

DM ≤45 words, TONE:
Saw your post about your appointment as Chief Medical Officer — lack of in-house clinical execution framework for early-phase oncology trials.  
A Clinical Trial Management System to streamline early-phase oncology trial setup and monitoring. ≈ TBD.  
Quick chat?```